Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BAE Systems lifts FY guidance after strong first half

(Sharecast News) - BAE Systems upgraded its full-year guidance on Wednesday following "another strong" performance in the first half against a market backdrop of increased defence spending. The company now expects full-year sales growth of between 8% and 10%, up from previous guidance of 7% to 9%. Underlying earnings before interest and tax are expected to grow between 9% and 11%, up from previous guidance of growth of between 8% and 10%.

It said the share price increase since the start of the year is expected to result in fewer shares being repurchased. This, along with a marginally higher tax rate, means BAE's guidance for earnings per share growth remained unchanged at between 8% and 10%.

For the six months ended 30 June, BAE reported a 13% increase in underlying EBIT to £1.6bn, while sales rose 11% to £14.6bn, with all sectors contributing growth.

The order intake fell to £13.2bn from £15.1bn in the same period a year earlier.

Chief executive Charles Woodburn said: "Our teams have delivered another strong operational and financial performance in the first half of the year, giving us the confidence to upgrade our guidance. In this heightened global threat environment, we continue to deliver mission critical capabilities to armed forces around the world and invest in our people, technologies and facilities to drive the improved efficiency, capacity and agility needed to meet the increasing demand for our highly relevant products and services.

"The breadth and depth of our geographic and product portfolio, together with our trusted track record of delivery, strengthen our confidence in the positive momentum of our business."

At 0945 BST, the shares were down 1.3% at 1,797.62p.

Russ Mould, investment director at AJ Bell, said: "Investors might not have liked the news it expects to buy back fewer shares following a strong run, nor the fact its earnings per share guidance has been left unchanged.

"Investors have lofty expectations for all defence stocks and they might have been banking on a significant upgrade to earnings guidance. Without that catalyst, the shares are vulnerable to a bout of profit taking.­­"

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.